Cumulus Oncology Limited

Burges Salmon’s Corporate Finance team has advised oncology drug discovery accelerator, Cumulus Oncology Limited, on a significant investment fundraise of c. £4.1 million. The investment fundraise follows Cumulus Oncology’s inaugural investment fundraise of £1.7m, which Burge